Advertisement

Gastric Cancer

, Volume 22, Issue 3, pp 526–526 | Cite as

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer

  • Shusuke Yagi
  • Takeru WakatsukiEmail author
  • Noriko Yamamoto
  • Keisho Chin
  • Daisuke Takahari
  • Mariko Ogura
  • Takashi Ichimura
  • Izuma Nakayama
  • Hiroki Osumi
  • Eiji Shinozaki
  • Mitsukuni Suenaga
  • Junko Fujisaki
  • Yuichi Ishikawa
  • Kensei Yamaguchi
  • Ken Namikawa
  • Yusuke Horiuchi
Open Access
Correction
  • 699 Downloads

Correction to: Gastric Cancer  https://doi.org/10.1007/s10120-018-0887-x

In the original publication of this article, Table 4 was published incorrectly. The correct Table 4 is given below.

Table 4

Comparison survivals between surgical specimens and biopsy specimens

 

Biopsy specimens

Surgical specimens

mPFS

 Homo-HER2

10.8 (95% CI 6.9–19.4)

20.0 (95% CI 17.8–22.2)

 Hetero-HER2

6.1 (95% CI 5.3–8.2)

6.0 (95% CI 2.3–9.7)

mOS

 Homo-HER2

29.3 (95% CI 20.5–NR)

NR

 Hetero-HER2

14.4 (95% CI 11.4–17.8)

14.0 (95% CI 11.9–16.1)

mPFS median progression-free survival, mOS median overall survival, NR not reached, Homo-HER2 homogeneously HER2 positive, Hetero-HER2 heterogeneously HER2 positive

The original article has been corrected. Publisher sincerely apologizes for the error.

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Shusuke Yagi
    • 1
  • Takeru Wakatsuki
    • 1
    Email author
  • Noriko Yamamoto
    • 2
  • Keisho Chin
    • 1
  • Daisuke Takahari
    • 1
  • Mariko Ogura
    • 1
  • Takashi Ichimura
    • 1
  • Izuma Nakayama
    • 1
  • Hiroki Osumi
    • 1
  • Eiji Shinozaki
    • 1
  • Mitsukuni Suenaga
    • 1
  • Junko Fujisaki
    • 1
  • Yuichi Ishikawa
    • 1
  • Kensei Yamaguchi
    • 1
  • Ken Namikawa
    • 1
  • Yusuke Horiuchi
    • 1
  1. 1.Department of GastroenterologyThe Cancer Institute Hospital of Japanese Foundation for Cancer ResearchTokyoJapan
  2. 2.Department of PathologyThe Cancer Institute Hospital of Japanese Foundation for Cancer ResearchTokyoJapan

Personalised recommendations